Amadix Overview

  • Founded
  • 2010
  • Status
  • Private
  • Employees
  • 29
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 9

Amadix General Information


Developer of medical technologies designed to detect tumours years in advance, before the symptoms appear. The company's technologies are oriented towards non-invasive early cancer detection, avoiding the complications of existing invasive procedures, as tumour biopsies, enabling doctors to provide suitable treatment to the patient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • Acera de Recoletos 2, 1B
  • 47004 Valladolid
  • Spain
+34 983 00 00 00

Amadix Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amadix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 27-Jan-2021 000.00 Completed Generating Revenue
10. Later Stage VC 19-Oct-2020 00000 000.00 Completed Generating Revenue
9. Later Stage VC 28-Nov-2019 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 22-Apr-2019 00000 00.00 Completed Generating Revenue
7. Later Stage VC 06-Nov-2018 00.000 00.000 Completed Generating Revenue
6. Secondary Transaction - Private 00.000 Completed Generating Revenue
5. Grant 03-Jul-2017 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 14-Dec-2016 00.00 00.000 Completed Generating Revenue
3. Early Stage VC 30-Dec-2015 $1.09M $5.05M Completed Generating Revenue
2. Early Stage VC 27-Dec-2012 $3.55M $3.96M Completed Generating Revenue
To view Amadix’s complete valuation and funding history, request access »

Amadix Executive Team (10)

Name Title Board Seat Contact Info
Rocio Arroyo Founder & Chief Executive Officer
Lucía Reinoso Chief Financial Officer
Beatriz Maroto Ph.D Chief Operating Officer
Pauline Dapena-Cherry Director, Business Development
Ana Martín Rodríguez Ph.D Scientific Director
You’re viewing 5 of 10 executive team members. Get the full list »

Amadix Board Members (11)

Name Representing Role Since
Ángel Santos Self President & Chairman 000 0000
Ferran Prat Self Scientific Advisory Board Member 000 0000
Francisco Armero Clave Board Member 000 0000
Joaquin Velasco Self Board Member 000 0000
Marina Rigau Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Amadix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amadix Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Health Accelerator/Incubator 000 0000 000000 0
CDTI Innvierte Corporation Minority 000 0000 000000 0
Centro para el Desarrollo Tecnológico Industrial Government Minority 000 0000 000000 0
Horizon 2020 Government 000 0000 000000 0
Alentia Capital Other Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Amadix Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000 08-Feb-2013 000000000000000000 Biotechnology
To view Amadix’s complete acquisitions history, request access »